Related Experiment Video

Updated: Aug 8, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

Hailong Tian1, Jiangjun Cao1, Bowen Li1

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.

Bone Research
|February 27, 2023
PubMed

Insights

Osteosarcoma immunotherapy shows promise for improving survival rates in adolescents. Nanomedicine offers advanced platforms to enhance treatment by targeting the tumor

Area of Science:

  • Oncology
  • Immunology
  • Nanomedicine

Background:

  • Osteosarcoma is the most common primary bone cancer in adolescents, with poor survival rates post-metastasis.
  • Current therapeutic strategies show limited improvement, highlighting the need for novel treatments.
  • Immunotherapy presents advantages over traditional methods, particularly in inhibiting metastasis.

Purpose of the Study:

  • To review key components of the osteosarcoma immune microenvironment.
  • To emphasize the application, progress, and prospects of osteosarcoma immunotherapy.
  • To discuss nanomedicine-based strategies for enhancing osteosarcoma treatment efficacy.

Main Methods:

  • Review of literature on osteosarcoma immune microenvironment.
  • Analysis of current osteosarcoma immunotherapy approaches.
  • Evaluation of nanomedicine applications in cancer treatment.

Main Results:

  • Key components of the osteosarcoma immune microenvironment and their functions are classified.
  • Advances in nanomedicine provide platforms for enhanced immunotherapy.
  • Nanomedicine-based options show potential for improving osteosarcoma treatment efficiency.

Conclusions:

  • Managing the immune microenvironment is crucial for understanding osteosarcoma heterogeneity and progression.
  • Nanomedicine-based immunotherapy offers a promising avenue for improving osteosarcoma treatment outcomes.
  • Future perspectives focus on overcoming standard treatment limitations through innovative immunotherapy strategies.

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.6K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K